TEGA THERAPEUTICS INC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets macromolecular chemistry and polymers, pharmaceuticals and biotechnology are QINGDAO JIULONG BIO PHARMACEUTICAL CO LTD, SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD and APTEVO BIOTHERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | United States | 2 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Macromolecular chemistry and polymers | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Macromolecular compounds compositions | |
#2 | Polysaccharides | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Therapeutic chemical compounds | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Glass Charles | 12 |
#2 | Thacker Bryan | 12 |
#3 | Esko Jeffrey | 11 |
#4 | Esko Jeffrey D | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021041711A1 | Heparin and heparan sulfate from modified mst cells and methods of making and using | |
AU2017378500A1 | In vitro heparin and heparan sulfate compositions and methods of making and using | |
EP3389674A1 | Cellular glycosaminoglycan compositions and methods of making and using |